GSK to pay up to $2.2B to settle almost all Zantac-related court cases
GSK said Wednesday that it is paying up to $2.2 billion to resolve 93% of its US state-based liability cases related to its heartburn medicine …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
